HSP90AA1 and hepatocellular carcinoma: As is the case with STA9090 or NB treatment, NTD or CTD deletion of Hsp90α reduced FASN (Fig. 4K) and lipid accumulation (Fig. 4L, M and supplemental Fig. S1D) in HCC cells.